LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,083,000 | +4.3% | 91,327 | 0.0% | 0.04% | -2.8% |
| Q3 2020 | $8,706,000 | -16.2% | 91,327 | -1.6% | 0.04% | -20.0% |
| Q2 2020 | $10,384,000 | +53.8% | 92,842 | 0.0% | 0.04% | +15.4% |
| Q1 2020 | $6,751,000 | -30.3% | 92,842 | 0.0% | 0.04% | -11.4% |
| Q4 2019 | $9,683,000 | +21.2% | 92,842 | +15.7% | 0.04% | +29.4% |
| Q3 2019 | $7,990,000 | -10.9% | 80,274 | +2.1% | 0.03% | -20.9% |
| Q2 2019 | $8,971,000 | +243.6% | 78,591 | +278.4% | 0.04% | +290.9% |
| Q1 2019 | $2,611,000 | +32537.5% | 20,770 | +74078.6% | 0.01% | – |
| Q3 2018 | $8,000 | -93.8% | 28 | -95.5% | 0.00% | -100.0% |
| Q2 2018 | $129,000 | -84.4% | 626 | -87.5% | 0.00% | -75.0% |
| Q1 2018 | $826,000 | +734.3% | 5,003 | +289.6% | 0.00% | – |
| Q1 2015 | $99,000 | -47.3% | 1,284 | -67.9% | 0.00% | -100.0% |
| Q3 2014 | $188,000 | – | 4,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |